Literature DB >> 8043892

Sodium retention and insulin treatment in insulin-dependent diabetes mellitus.

K Nørgaard1, B Feldt-Rasmussen.   

Abstract

The hypothesis that total body exchangeable sodium (ENa) is elevated in type 1 (insulin-dependent) diabetic patients with short-duration diabetes and no signs of microangiopathy was tested. Also tested was whether peripheral hyperinsulinaemia, in terms of the amounts of insulin injected subcutaneously, contributes to the increased ENa. Three studies were performed. Study 1 was a cross-sectional study comprising 28 type 1 diabetic men (aged 18-35 years) with short-duration diabetes (< 5 years) and no signs of diabetic complications, and 22 control subjects. Study 2 was a prospective study of 17 newly diagnosed diabetic patients (aged 20-35 years, median 27 years) who were studied on two occasions on different insulin doses. Study 3 was a 12-month prospective intervention study of 21 type 1 diabetic patients with incipient nephropathy, who had been randomized either to receive continuous subcutaneous insulin infusion for improvement of glycaemic control or to remain on conventional insulin treatment. In study 1, ENa was higher in short-duration type 1 diabetic men than in controls (3003 +/- 325 vs 2849 +/- 207 mEq/1.73 m2, P < 0.05) and was correlated significantly with the insulin dose (r = 0.38, P < 0.05). In study 2, of the newly diagnosed diabetic patients, 11 received a reduced insulin dose and 6 an increased dose as compared with the initial study. ENa was reduced in all patients receiving less insulin (P < 0.001) and remained unchanged in patients receiving more insulin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043892     DOI: 10.1007/bf00580755

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  23 in total

Review 1.  Microalbuminuria and clinical nephropathy in type 1 (insulin-dependent) diabetes mellitus: pathophysiological mechanisms and intervention studies.

Authors:  B Feldt-Rasmussen
Journal:  Dan Med Bull       Date:  1989-10

2.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

3.  Exchangable sodium determinations by an isotope balance and a whole-body counter method. Comparison of measured changes of sodium stores in man by these methods and by balance.

Authors:  R G Evens; L Baer; J R Gill; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1968-11       Impact factor: 5.958

4.  Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy.

Authors:  B Feldt-Rasmussen; B Dinesen; M Deckert
Journal:  Scand J Clin Lab Invest       Date:  1985-10       Impact factor: 1.713

Review 5.  The effect of insulin on renal sodium metabolism. A review with clinical implications.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

6.  Effects of insulin on kidney function and sodium excretion in healthy subjects.

Authors:  P Skøtt; O Hother-Nielsen; N E Bruun; J Giese; M D Nielsen; H Beck-Nielsen; H H Parving
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

7.  Normal renal tubular response to changes of sodium intake in hypertensive man.

Authors:  N E Bruun; P Skøtt; M Damkjaer Nielsen; S Rasmussen; H J Schütten; A Leth; E B Pedersen; J Giese
Journal:  J Hypertens       Date:  1990-03       Impact factor: 4.844

8.  Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert; J Giese; N J Christensen; L Bent-Hansen; M D Nielsen
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

9.  Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy.

Authors:  J A O'Hare; J B Ferriss; D Brady; B Twomey; D J O'Sullivan
Journal:  Hypertension       Date:  1985 Nov-Dec       Impact factor: 10.190

10.  Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy.

Authors:  B Feldt-Rasmussen; E R Mathiesen; L Hegedüs; T Deckert
Journal:  N Engl J Med       Date:  1986-03-13       Impact factor: 91.245

View more
  4 in total

1.  NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes.

Authors:  Jing Yang; Jennifer S Pollock; Pamela K Carmines
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

2.  PP2B-dependent NO production in the medullary thick ascending limb during diabetes.

Authors:  Jan M Foster; Pamela K Carmines; Jennifer S Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-20

Review 3.  Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Authors:  Cecilia C Low Wang; Connie N Hess; William R Hiatt; Allison B Goldfine
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

4.  Interaction between NO synthase and NADPH oxidase in control of sodium transport by the renal thick ascending limb during diabetes.

Authors:  C De Miguel; J M Foster; P K Carmines; J S Pollock
Journal:  Acta Physiol (Oxf)       Date:  2013-07-25       Impact factor: 6.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.